Internationalization is at the core of IBEC’s scientific and training strategy. Actions enhancing IBEC’s international profile are designed to foster exchange in complementary techniques and trigger new collaborations, as well … Read more
Researchers at IBEC have identified a potential way to slow down the neurodegenerative progression of Parkinson’s disease. They focused their work on the cellular prion protein (PrPc), a specialized molecule located in the membranes of neurons that’s involved in a number of functions such as cell cycle control and neurotransmission.
Today, the tenth international Rare Disease Day, IBEC is taking part in an event at the Hospital Sant Joan de Déu.Organised by the Federación Española de Enfermedades Raras (FEDER), the Federació Catalana de Malalties Minoritàries (FECAMM) and the Plataforma de Malalties Minoritàries, and supported by GENCAT, CatSalut and the Parlament de Catalunya, the open conference will emphasize the importance of research in tackling rare diseases.
Josep Samitier will take part in a round table at the conference, during which he will present bioengineering applied to rare diseases.
On Friday 12th May 2017 we’ll open our doors again to undergraduate and masters students interested in a research career.
On Friday 12th May 2017 we’ll open our doors again to undergraduate and masters students interested in a research career.
On Friday 12th May 2017 we’ll open our doors again to undergraduate and masters students interested in a research career.
On Friday 12th May 2017 we’ll open our doors again to undergraduate and masters students interested in a research career.
Organized by the IBEC PhD Committee
Organized by the IBEC PhD Committee
On Friday last week MECHANO-CONTROL, the largest European project ever coordinated at IBEC, held its kick-off meeting at the institute. Pere Roca-Cusachs’ project, which is funded by H2020’s FET Proactive programme, will focus on understanding and controlling how cells transmit and detect mechanical forces, with the aim of coming up with new therapeutic and diagnostic approaches for cancer and other diseases.